osimertinib
astrazeneca
['adaura', 'nsclc', 'lcsm,(-blcsm)', 'sclc', 'osimertinib', 'aura ,(-laura)']
#asco23: new adaura data reinforce adjuvant osimertinib as the standard of care for patients with resected egfr-mutated stage ib to iiia #nsclc: #ascodailynews #lcsm 
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.